Identification of potential molecular biomarkers in response to thioredoxin reductase 1 deficiency under nickel exposure

Biochip Journal

Volumn 6, Issue 2, 2012, Pages 157-164

  Kim, Hye Lim ^a,b,c   Seo, Young Rok ^a,b,c  

^a Department of Life Science ^*  (Denmark)

^b Dongguk University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

DNA damage; Nickel; Pathway analysis; Thioredoxin reductase 1; Toxicogenomics

Indexed keywords

CELL DEATH; CELL PROLIFERATION; CHEMICAL COMPOUNDS; DNA; GENES; NICKEL COMPOUNDS; TOXICITY;

CANDIDATE GENES; CELL SURVIVAL; CYTOPROTECTION; DEFENSE SYSTEM; DNA DAMAGES; DNA LESIONS; DNA REPAIR; DNA STRAND BREAK; ENVIRONMENTAL CONTAMINANT; ENVIRONMENTAL TOXICANTS; GENE-ENVIRONMENT INTERACTION; HUMAN DISEASE; IMMUNOFLUORESCENCE STAINING; MICROARRAY ANALYSIS; MOLECULAR BIOMARKER; PATHWAY ANALYSIS; REDOX FACTORS; THIOREDOXIN REDUCTASE; TOXIC METALS; TOXICOGENOMICS; WILD-TYPE CELLS;

NICKEL;

AHNAK NUCLEOPROTEIN; BIOLOGICAL MARKER; CELL CYCLE PROTEIN 20; GALECTIN 7; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; MEMBRANE PROTEIN; MOLECULAR MARKER; NICKEL; NUCLEOPROTEIN; PHOSPHOLIPASE D1; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1F; PROTEIN; RAS HOMOLOG GENE FAMILY, MEMBER B; RETICULOCALBIN 1, EF HAND CALCIUM BINDING DOMAIN; SECRETED FRIZZLED RELATED PROTEIN 1; STRESS ACTIVATED PROTEIN KINASE 1; THIOREDOXIN REDUCTASE 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; GENE CONTROL; GENE FUNCTION; GENE SILENCING; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INDUSTRIALIZATION; INFLAMMATION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POLLUTANT; UPREGULATION;

EID: 84862578464     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-012-6208-2     Document Type: Article

References (42)

1. Grandjean, P., Andersen, O. & Nielsen, G. D. Carcinogenicity of occupational nickel exposures: an evaluation of the epidemiological evidence. Am. J. Ind. Med. 13, 193-209 (1988).
2. Sunderman, F. W. Jr. Nasal toxicity, carcinogenicity, and olfactory uptake of metals. Ann. Clin. Lab. Sci. 31, 3-24 (2001).
3. Kasprzak, K. S., Sunderman, F. W. Jr. & Salnikow, K. Nickel carcinogenesis. Mutat. Res. 533, 67-97 (2003).
4. Robison, S. H., Cantoni, O. & Costa, M. Analysis of metal-induced DNA lesions and DNA-repair replication in mammalian cells. Mutat. Res. 131, 173-181 (1984).
5. Patierno, S. R. & Costa, M. DNA-protein cross-links induced by nickel compounds in intact cultured mammalian cells. Chem. Biol. Interact. 55, 75-91 (1985).
6. Sen, P. & Costa, M. Induction of chromosomal damage in Chinese hamster ovary cells by soluble and particulate nickel compounds: preferential fragmentation of the heterochromatic long arm of the X-chromosome by carcinogenic crystalline NiS particles. Cancer Res. 45, 2320-2325 (1985).
7. Zhong, Z. J., Troll, W., Koenig, K. L. & Frenkel, K. Carcinogenic sulfide salts of nickel and cadmium induce H2O2 formation by human polymorphonuclear leukocytes. Cancer Res. 50, 7564-7570 (1990).
8. Kasprzak, K. S. The role of oxidative damage in metal carcinogenicity. Chem. Res. Toxicol. 4, 604-615 (1991).
9. Kawanishi, S. et al. Oxidative DNA damage in cultured cells and rat lungs by carcinogenic nickel compounds. Free Radic. Biol. Med. 31, 108-116 (2001).
10. Kasprzak, K. S. & Hernandez, L. Enhancement of hydroxylation and deglycosylation of 2′-deoxyguanosine by carcinogenic nickel compounds. Cancer Res. 49, 5964-5968 (1989).
11. Mustacich, D. & Powis, G. Thioredoxin reductase. Biochem J. 346, 1-8 (2000).
12. Berggren, M. et al. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res. 16, 3459-3466 (1996).
13. Williams, C. H. et al. Thioredoxin reductase: two modes of catalysis have evolved. Eur. J. Biochem. 267, 6110-6119 (2000).
14. Oberley, T. D., Verwiebe, E., Zhong, W., Kang, S. W. & Rhee, S. G. Localization of the thioredoxin system in normal rat kidney. Free Radic. Biol. Med. 30, 412-424 (2001).
15. Hirota, K. et al. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem. Biophys. Res. Commun. 274, 177-182 (2000).
16. Karimpour, S. et al. Thioredoxin reductase regulates AP-1 activity as well as thioredoxin nuclear localization via active cysteines in response to ionizing radiation. Oncogene21, 6317-6327 (2002).
17. Koizumi, S. & Yamada, H. DNA microarray analysis of altered gene expression in cadmium-exposed human cells. J. Occup. Health45, 331-334 (2003).
18. Carinci, F. et al. Zirconium oxide: analysis of MG63 osteoblast-like cell response by means of a microarray technology. Biomaterials25, 215-228 (2004).
19. Boverhof, D. R. & Zacharewski, T. R. Toxicogenomics in risk assessment: applications and needs. Toxicol. Sci. 89, 352-360 (2006).
20. Werner, T. Bioinformatics applications for pathway analysis of microarray data. Curr. Opin. Biotechnol. 19, 50-54 (2008).
21. Snow, E. T. Metal carcinogenesis: mechanistic implications. Pharmacol. Ther. 53, 31-65 (1992).
22. Ercal, N., Gurer-Orhan, H. & Aykin-Burns, N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr. Top. Med. Chem. 1, 529-539 (2001).
23. Kim, H. L. & Seo, Y. R. Synergistic genotoxic effect between gene and environmental pollutant: Oxidative DNA damage induced by thioredoxin reductase 1 silencing under nickel treatment. Mol. Cell. Toxicol. 7, 251-257 (2011).
24. Zhou, C. et al. DNA damage evaluated by gamma H2AX foci formation by a selective group of chemical/physical stressors. Mutat. Res. 604, 8-18 (2006).
25. Hieda, Y., Tsukita, S. & Tsukita, S. A new high molecular mass protein showing unique localization in desmosomal plaque. J. Cell Biol. 109, 1511-1518 (1989).
26. Salim, C., Boxberg, Y. V., Alterio, J., Féréol, S. & Nothias, F. The giant protein AHNAK involved in morphogenesis and laminin substrate adhesion of myelinating Schwann cells. Glia57, 535-549 (2009).
27. Lu, Z. et al. Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Mol. Cell Biol. 20, 462-467 (2000).
28. Hui, L. et al. holipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Mol. Cell Biol. 24, 5677-5686 (2004).
29. Fritz, G. & Kaina, B. rhoB encoding a UV-inducible Ras-related small GTP-binding protein is regulated by GTPases of the Rho family and independent of JNK, ERK, and p38 MAP kinase. J. Biol. Chem. 272, 30637-30644 (1997).
30. Saini, S. et al. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas. Cancer Res. 69, 6815-6822 (2009).
31. Abba, M. C. et al. Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression. Breast Cancer Res. 6, R499-R513 (2004).
32. Yang, G., Xu, Y., Chen, X. & Hu, G. IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene26, 594-603 (2007).
33. Cellurale, C. et al. Role of JNK in a Trp53-dependent mouse model of breast cancer. PLoS One5, e12469 (2010).
34. Ozawa, M. Cloning of a human homologue of mouse reticulocalbin reveals conservation of structural domains in the novel endoplasmic reticulumresident Ca (2+)-binding protein with multiple EF-hand motifs. J. Biochem. 117, 1113-1119 (1995).
35. Yoshida, Y. et al. Limited expression of reticulocalbin-1 in lymphatic endothelial cells in lung tumor but not in normal lung. Biochem. Biophys. Res. Commun. 405, 610-614 (2011).
36. Canguilhem, B. et al. RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling. J. Biol. Chem. 280, 43257-43263 (2005).
37. Bodine, P. V. et al. The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis. J. Cell. Biochem. 96, 1212-1230 (2005).
38. Johnson, G. L. & Nakamura, K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim. Biophys. Acta1773, 1341-1348 (2007).
39. d'Errico, A., Malats, N., Vineis, P. & Boffetta, P. Review of studies of selected metabolic polymorphisms and cancer. IARC Sci. Publ. 148, 323-393 (1999).
40. Peng, X. et al. Statistical implications of pooling RNA samples for microarray experiments. BMC Bioinformatics4, 1-9 (2003).
41. Nikitin, A., Egorov, S., Daraselia, N. & Mazo, I. Pathway studio-the analysis and navigation of molecular networks. Bioinformatics19, 2155-2157 (2003).
42. Kwon, J. Y., Kim, J. M., Ji, Y. H. & Seo, Y. R. Genomewide microarray investigation of molecular targets and signaling networks in response to high-LET neutron in in vivo-mimic spheroid of human carcinoma. Mol. Cell. Toxicol. 8, 9-18 (2012).